Showing results (1731-1740 of 1,776) with videos related to
Sort By:
Pageof 178
The Journal of Antimicrobial Chemotherapy|May 16, 2015
A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal originYang Wang, Yuan Lv, Jiachang Cai, et al.JACC. Asia|September 5, 2025
Multicenter Practice of Non/Minimized Fluoroscopy Ablation for Paroxysmal AF in China: The PAF-ICE TrialYunhe Wang, Deyong Long, Fangyi Xiao, et al.International Immunopharmacology|August 31, 2025
Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune responseYuting Zhang, Jing Yuan, Aodi Wu, et al.Journal of Biotechnology|March 17, 2017
Mechanistic understanding of the cysteine capping modifications of antibodies enables selective chemical engineering in live mammalian cellsXiaotian Zhong, Tao He, Amar S Prashad, et al.Scientific Reports|March 23, 2018
Phosphoinositides regulate the TCR/CD3 complex membrane dynamics and activationNassima Chouaki Benmansour, Kilian Ruminski, Anne-Marie Sartre, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 18, 2022
Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newbornsFrédéric M Vaz, Youssra Jamal, Rob Barto, et al.Veterinary Microbiology|February 10, 2026
Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune responseYuting Zhang, Jing Yuan, Aodi Wu, et al.Journal of the American Heart Association|October 6, 2021
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection FractionApril F Mohanty, Emily B Levitan, Jordan B King, et al.Nature Communications|April 23, 2021
Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2Qing-Tao He, Peng Xiao, Shen-Ming Huang, et al.The Journal of Pharmacology and Experimental Therapeutics|May 13, 2018
Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic ApplicationChuan Shen, Andrea Iskenderian, Dianna Lundberg, et al.Pageof 178